YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer

NCT00050297 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: YM598

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]